Additionally, there were increased cytotoxicity and apoptosis gene expression signatures in SC1 on-treatment that supported an increase in tumor cytotoxicity as evaluated by increase in cleaved caspase-3 expression in the tumor compartment and perforin release (Fig. 3D). This evidence concerns the gene PRF1 and neoplasm.